Epigral (NSE:EPIGRAL) ROCE %: 17.94% (As of Mar. 2026)


NSE:EPIGRAL Epigral Ltd NSE:EPIGRAL
88 GF Score
Price ₹1,113.10
GF Value ₹1,754.72
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Epigral ROCE %?

Epigral NSE:EPIGRAL +0.62% 88 ROCE % is 17.94% as of Mar. 2026. GuruFocus rates NSE:EPIGRAL with a GF Score™ of 88/100 and a GF Value™ of ₹1,754.72 (Significantly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Epigral's annualized ROCE % for the quarter that ended in Mar. 2026 was 17.94%.

Epigral  (NSE:EPIGRAL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Epigral ROCE % Related Terms

Epigral ROCE % Historical Data

* Premium members only.

The historical data trend for Epigral's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epigral ROCE % Chart

Epigral Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only 31.33 33.90 18.59 24.99 14.21

Epigral Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.54 19.63 13.39 9.59 17.94
NSE:EPIGRAL
88GF Score
Epigral Ltd NSE:EPIGRAL
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epigral ROCE % Calculation

Epigral's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=3874.1/( ( (31524.4 - 4955.9) + (35053 - 7104.2) )/ 2 )
=3874.1/( (26568.5+27948.8)/ 2 )
=3874.1/27258.65
=14.21 %

Epigral's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=5013.6/( ( (0 - 0) + (35053 - 7104.2) )/ 1 )
=5013.6/( ( 0 + 27948.8 )/ 1 )
=5013.6/27948.8
=17.94 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 17.94% mean?
Epigral (NSE:EPIGRAL) has a ROCE % of 17.94% as of Mar. 2026.
Is Epigral's ROCE % too high?
Epigral's current ROCE % is 17.94%. The Chemicals industry median ROCE % is 6.42. Epigral's value of 17.94% is 179.4% above this industry median. Overall, Epigral has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Epigral's ROCE % compare to DOW?
Epigral's ROCE % of 17.94% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.42. Epigral's value of 17.94% is 179.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Chemicals company?
The median ROCE % among Chemicals companies is 6.42, based on 1,590 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Epigral's current ROCE % of 17.94% is 179.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epigral's current ROCE % is 17.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epigral stock overvalued right now?
Based on GuruFocus' analysis, Epigral (NSE:EPIGRAL) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,754.72, compared to a current price of ₹1,113.10 — trading 36.6% below its estimated fair value. The current ROCE % is 17.94% and 179.4% above the Chemicals industry median of 6.42. Epigral's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Epigral (NSE:EPIGRAL), the current ROCE % is 17.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Epigral (NSE:EPIGRAL) Overvalued in 2026?

Based on GuruFocus' analysis, Epigral stock appears to be undervalued. The current stock price of ₹1,113.10 is trading 36.6% below its estimated GF Value™ of ₹1,754.72. GuruFocus considers Epigral to be Significantly Undervalued.

Key valuation signals for NSE:EPIGRAL:

  • ROCE %: 17.94%
  • GF Value™: ₹1,754.72 vs. price of ₹1,113.10 (36.6% below fair value)
  • GF Score™: 88/100 with 5 warning signs
  • Industry Position: 179.4% above the Chemicals median

No single metric tells the full story. See the NSE:EPIGRAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Epigral Business Description

Other Exchanges 543332:India
Address Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015
Epigral Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.
88GF Score

Get the complete analysis for NSE:EPIGRAL

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,113.10
Price
₹1,754.72
GF Value